Aliko Scientific is a multinational group focused on advancing cancer diagnostics through integrated technologies in cytology, molecular biology, and digital pathology. Headquartered in Italy and the USA and listed on Euronext Growth Paris, the Group oversees Ikonisys, a leader in automated FISH diagnostics, and Hospitex International, a key player in cytology systems. By combining proprietary hardware, reagents, software, and AI, Aliko delivers scalable diagnostic platforms that enhance early detection, accuracy, and lab efficiency. Its solutions integrate cytological and molecular analysis into a unified workflow, enabling high-throughput screening, reliable results, and optimized sample use. With certified technologies (ISO, FDA, IVDR) and a growing global presence, Aliko Scientific continues to expand through innovation, partnerships, and strategic acquisitions.